Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study

Background: Diabetic nephropathy is a severe complication of Type 2 diabetes. Tubular lesions may play an important role in its early stages. The aim of our study was to determine if atorvastatin protects the podocytes and the proximal tubule in patients with Type 2 diabetes. Methods: A total of 63...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlad, Adrian, Vlad, Mihaela, Petrica, Ligia, Ursoniu, Sorin, Gadalean, Florica, Popescu, Roxana, Vlad, Daliborca, Dumitrascu, Victor, Gluhovschi, Gheorghe, Gluhovschi, Cristina, Velciov, Silvia, Bob, Flaviu, Matusz, Petru, Secara, Alina, Simulescu, Anca, Jianu, Dragos Catalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014491/
https://www.ncbi.nlm.nih.gov/pubmed/27841047
http://dx.doi.org/10.1080/0886022X.2016.1254657

Ejemplares similares

Ejemplares similares